| Imagery Source: Wikimedia Commons / Harrison Keely |
| Information Source: CVS Health Corporation |
| First quarter financial highlights |
- Total revenues increased to $94.6 billion, up 7.0% compared to the prior year
|
- GAAP diluted EPS of $1.41 and Adjusted EPS of $2.25
|
- Generated cash flow from operations of $4.6 billion
|
| Operational highlights |
- CVS Health® to exit the individual exchange business
|
- Aetna® introduces new solutions to ease the patient and provider experience
|
- CVS Caremark® makes formulary update to improve access to GLP-1 drugs
|
| 2025 Full-year guidance |
- Revised GAAP diluted EPS guidance range to $4.23 to $4.43 from $4.58 to $4.83
|
- Raised Adjusted EPS guidance range to $6.00 to $6.20 from $5.75 to $6.00
|
- Raised cash flow from operations guidance to approximately $7.0 billion from approximately $6.5 billion
|
| CEO commentary |
| “As we aim to be the most trusted health care company in America, we are driving greater care, value, and service from our integrated, industry-leading businesses. Thanks to a resolute focus on customers, our colleagues across CVS Health delivered positive results across our Health Care Benefits, Health Services and Pharmacy & Consumer Wellness segments, as we continue to build a world of better health around the 185 million consumers we are privileged to serve.” David Joyner, CVS Health President and CEO |
| CVS Health Corporation (NYSE: CVS) today announced operating results for the three months ended March 31, 2025. |
|
Financial results summary |
| First quarter GAAP diluted EPS of $1.41 increased from $0.88 in the prior year and Adjusted EPS of $2.25 increased from $1.31 in the prior year, primarily due to an increase in the Health Care Benefits segment’s operating results, which reflects favorable year-over-year impact of prior-year development and improved underlying performance in Medicare, including the impact of improved Medicare Advantage star ratings for the 2025 payment year. |
| The Company updated its full-year 2025 GAAP diluted EPS, Adjusted EPS and cash flow from operations guidance to reflect strong performance across each of our businesses, while maintaining a cautious view for the remainder of the year in light of continued elevated cost trends and the potential for macro headwinds. |
| For the full document, click the link below |
| CVS Health Corporation |
| Stay ahead of the curve! Subscribe to InsidEntity for daily updates on all your favourite companies. |
